Literature DB >> 22219034

Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer.

Reo Maruyama1, Hiromu Suzuki, Eiichiro Yamamoto, Kohzoh Imai, Yasuhisa Shinomura.   

Abstract

Epigenetic changes, including DNA methylation and histone modification, play key roles in the dysregulation of tumor-related genes, thereby affecting numerous cellular processes, including cell proliferation, cell adhesion, apoptosis, and metastasis. In recent years, numerous studies have shown that noncoding RNAs (ncRNAs) are key players in the initiation and progression of cancer and epigenetic mechanisms are deeply involved in their dysregulation. Indeed, the growing list of microRNA (miRNA) genes aberrantly methylated in cancer suggests that a large number of miRNAs exert tumor-suppressive or oncogenic effects. In addition, it now appears that long ncRNAs may be causally related to epigenetic dysregulation of critical genes in cancer. Dissection of the relationships between ncRNAs and epigenetic alterations may lead to the development of novel approaches to the diagnosis and treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219034     DOI: 10.1007/s13277-011-0308-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  83 in total

Review 1.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

3.  miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.

Authors:  Ming Liu; Nan Lang; Meng Qiu; Feng Xu; Qiu Li; Qiulin Tang; Ji Chen; Xi Chen; Siyuan Zhang; Zhen Liu; Jitao Zhou; Yajie Zhu; Yu Deng; Yi Zheng; Feng Bi
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

4.  MiR-9 downregulates CDX2 expression in gastric cancer cells.

Authors:  Pichayanoot Rotkrua; Yoshimitsu Akiyama; Yutaka Hashimoto; Takeshi Otsubo; Yasuhito Yuasa
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

5.  The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

Authors:  Naïma Hanoun; Yannick Delpu; Arief A Suriawinata; Barbara Bournet; Christophe Bureau; Janick Selves; Gregory J Tsongalis; Marlène Dufresne; Louis Buscail; Pierre Cordelier; Jérôme Torrisani
Journal:  Clin Chem       Date:  2010-04-29       Impact factor: 8.327

6.  Frequent downregulation of miR-34 family in human ovarian cancers.

Authors:  David C Corney; Chang-Il Hwang; Andres Matoso; Markus Vogt; Andrea Flesken-Nikitin; Andrew K Godwin; Aparna A Kamat; Anil K Sood; Lora H Ellenson; Heiko Hermeking; Alexander Yu Nikitin
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

7.  Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.

Authors:  Saskia M Wilting; Robert A A van Boerdonk; Florianne E Henken; Chris J L M Meijer; Begona Diosdado; Gerrit A Meijer; Carlos le Sage; Reuven Agami; Peter J F Snijders; Renske D M Steenbergen
Journal:  Mol Cancer       Date:  2010-06-26       Impact factor: 27.401

8.  High-throughput methylation profiling by MCA coupled to CpG island microarray.

Authors:  Marcos R H Estécio; Pearlly S Yan; Ashraf E K Ibrahim; Carmen S Tellez; Lanlan Shen; Tim H-M Huang; Jean-Pierre J Issa
Journal:  Genome Res       Date:  2007-09-04       Impact factor: 9.043

9.  Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.

Authors:  U Lehmann; B Hasemeier; M Christgen; M Müller; D Römermann; F Länger; H Kreipe
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

10.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

View more
  15 in total

1.  Sperm-borne miRNAs and endo-siRNAs are important for fertilization and preimplantation embryonic development.

Authors:  Shuiqiao Yuan; Andrew Schuster; Chong Tang; Tian Yu; Nicole Ortogero; Jianqiang Bao; Huili Zheng; Wei Yan
Journal:  Development       Date:  2015-12-30       Impact factor: 6.868

2.  Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.

Authors:  Meng Yang; Xu Zhai; Bairong Xia; Yanying Wang; Ge Lou
Journal:  Tumour Biol       Date:  2015-04-29

Review 3.  Noncoding RNAs in endocrine malignancy.

Authors:  Jessica Kentwell; Justin S Gundara; Stan B Sidhu
Journal:  Oncologist       Date:  2014-04-09

4.  A randomized clinical trial of nerve block to manage end-stage pancreatic cancerous pain.

Authors:  Ling Gao; Yi-jin Yang; Hai-yan Xu; Jin Zhou; Han Hong; Yun-liang Wang; De-chun Li
Journal:  Tumour Biol       Date:  2013-10-26

5.  Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer.

Authors:  Xiao-Lin Wang; Hu-Yang Xie; Chuan-Dong Zhu; Xiao-Fang Zhu; Guang-Xin Cao; Xiao-Hong Chen; Han-Feng Xu
Journal:  Tumour Biol       Date:  2014-10-11

6.  Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients.

Authors:  Alexandra Søgaard Helbo; Marianne Treppendahl; Derya Aslan; Konstantinos Dimopoulos; Cecilie Nandrup-Bus; Mette Skov Holm; Mette Klarskov Andersen; Gangning Liang; Lasse Sommer Kristensen; Kirsten Grønbæk
Journal:  Genes (Basel)       Date:  2015-10-14       Impact factor: 4.096

Review 7.  A Looking-Glass of Non-coding RNAs in oral cancer.

Authors:  Alexandra Iulia Irimie; Cornelia Braicu; Laura Sonea; Alina Andreea Zimta; Roxana Cojocneanu-Petric; Konstantin Tonchev; Nikolay Mehterov; Diana Diudea; Smaranda Buduru; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

8.  The Long Noncoding RNA D63785 Regulates Chemotherapy Sensitivity in Human Gastric Cancer by Targeting miR-422a.

Authors:  Zhixia Zhou; Zhijuan Lin; Yuqi He; Xin Pang; Yin Wang; Murugavel Ponnusamy; Xiang Ao; Peipei Shan; Muhammad Akram Tariq; Peifeng Li; Jianxun Wang
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-05       Impact factor: 8.886

9.  Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.

Authors:  Li-Ming Gao; Shu-Feng Xu; Yue Zheng; Ping Wang; Ling Zhang; Shan-Shan Shi; Tong Wu; Yang Li; Jing Zhao; Qi Tian; Xiao-Bo Yin; Lei Zheng
Journal:  J Cell Mol Med       Date:  2019-07-17       Impact factor: 5.310

Review 10.  Epigenetic regulation of long non-coding RNAs in gastric cancer.

Authors:  Zhixia Zhou; Zhijuan Lin; Xin Pang; Muhammad Akram Tariq; Xiang Ao; Peifeng Li; Jianxun Wang
Journal:  Oncotarget       Date:  2017-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.